Roche Reports 4 Percent Growth in Diagnostics for Q1 | GenomeWeb

NEW YORK (GenomeWeb) – Roche on Tuesday reported a 4 percent increase in diagnostics sales for the first quarter of 2016, spurred by growth in three of its four diagnostics businesses.

Overall, the Swiss pharmaceutical and diagnostics company reported CHF 12.41 billion ($12.92 billion) in quarterly sales, a 5 percent increase over last year, when sales totaled CHF 11.83 billion. On a constant currency basis, Roche's sales grew 4 percent in the first quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.

Sponsored by
Agilent Technologies

In this online seminar, speakers from the Center for Personalized Diagnostics at Penn Medicine will discuss the design and technical validation of a custom next-generation sequencing panel to detect mutations in a wide array of tumor types.